NCT05491603View on ClinicalTrials.gov

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis

PHASE2SuspendedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Onychomycosis
Interventions
BIOLOGICAL

DBI-001

Topically administered

BIOLOGICAL

DBI-002

Topically administered

BIOLOGICAL

Aqueous Gel

Topically administered

Trial Locations (5)

55112

Minnesota Clinical Study Center, New Brighton

78759

DermResearch, Austin

91436

T. Joseph Raoof MD, Inc./Encino Research Center, Encino

97210

Oregon Dermatology and Research Center, Portland

98012

North Sound Dermatology, Mill Creek

Sponsors

Lead Sponsor

DermBiont, Inc.
All Listed Sponsors
lead

DermBiont, Inc.

INDUSTRY